Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer

18k
Total downloads
72k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 30 Jun 2025

Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients

Zhenjie Guan
Xinyu Gu
Lian Zheng

doi 10.3389/fimmu.2025.1609175

349 views

ORIGINAL RESEARCH

Published on 17 Jun 2025

Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma

Xiangyu Zhai
Kecheng Li
Hailing Ding
Yanmei Wu
Xinlu Zhang
Hao Zhang
Huaxin Zhou
Chongzhong Liu
Zili Zhang
Bin Jin

doi 10.3389/fimmu.2025.1602831

670 views

ORIGINAL RESEARCH

Published on 11 Jun 2025

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed

Meng Li-Fei
Si-Meng Ren
Jun Wang
Wei-Jun Zhao
Jian Chen
Wen-Tao Hu

doi 10.3389/fimmu.2025.1601982

671 views

ORIGINAL RESEARCH

Published on 10 Jun 2025

Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer

Chuanzhi Chen
Jiahui Qi
Weichao Lin
Chunlan Fu
Xin Jin

doi 10.3389/fimmu.2025.1590951

1,207 views

ORIGINAL RESEARCH

Published on 09 Jun 2025

TMEM115: a promising marker for glioma immunotherapy and prognosis

Hang Yin
Feng Wang
Haiyan Xu
Manyu Xu
Pengpeng Lu
Xiaojing Zhang
Lei Yang
Bing Lu
Pingping Sun
Jianfei Huang

doi 10.3389/fimmu.2025.1598499

1,048 views

MINI REVIEW

Published on 02 Jun 2025

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations

Xinyu Li
Hui Qiu
Qiuji Wu

doi 10.3389/fimmu.2025.1601572

1,124 views

ORIGINAL RESEARCH

Published on 13 May 2025

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation

Jiaoyun Lu
Furong Luo

doi 10.3389/fonc.2025.1595485

862 views

ORIGINAL RESEARCH

Published on 05 May 2025

TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response

Lin-De Sun
Lin-Lin Zhang
Zheng Wan
Xiao-Dong Yang
Jing Yao
Ze-Long Yang
Lin Liu
Jun-Yan Liu

doi 10.3389/fimmu.2025.1578068

1,617 views

ORIGINAL RESEARCH

Published on 17 Apr 2025

The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients

Hao Zhang
Zirui Zhuang
Li Hong
Ruipeng Wang
Jinjing Xu
Youyuan Tang

doi 10.3389/fimmu.2025.1589678

1,492 views

ORIGINAL RESEARCH

Published on 16 Apr 2025

Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma

Kun Zhang
Huyang Xie
Fan Zhao
Yeqing Huang

doi 10.3389/fimmu.2025.1564784

1,387 views

MINI REVIEW

Published on 08 Apr 2025

The role of tumor-associated macrophages in HPV induced cervical cancer

Zeping Chen
Binzhu Zhao

doi 10.3389/fimmu.2025.1586806

2,366 views

MINI REVIEW

Published on 02 Apr 2025

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances

Dong Xie
Yang Liu
Fangbiao Xu
Zhibo Dang
Mengge Li
Qinsheng Zhang
Zhongqin Dang

doi 10.3389/fimmu.2025.1581098

2,909 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Molecular and Cellular Oncology
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

72kTopic views
48kArticle views
18kArticle downloads

View impact

Articles

Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients

Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed

Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer

TMEM115: a promising marker for glioma immunotherapy and prognosis

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation

TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response

The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients

Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma

The role of tumor-associated macrophages in HPV induced cervical cancer

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy

Molecular and Cellular Oncology